Form 4 for GILD Gilead Sciences
Accepted 2022-04-29 00:00:00 ET · period of report 2022-04-28 · accession 0001127602-22-012762 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-04-29 | 2022-04-28 | GILD | Lofton Kevin E | Dir | M - OptEx | $25.63 | +16.3K | 90.5K | +22% | +$418.3K |
| D | 2022-04-29 | 2022-04-28 | GILD | Lofton Kevin E | Dir | M - OptEx | $0.00 | -16.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-28 | M | A | 16,322 | $25.63 | 90,525 | I By Trust | — | — | (F1) Includes 61,207 shares held in a Revocable Living Trust and 29,318 shares held in a Grantor Retained Annuity Trust. |
| 2 | Derivative | Non-qualified Stock Option (Right to Buy) | 2022-04-28 | M | D | 16,322 | $0.00 | 0 | D | $25.63 · — to 2022-05-10 | 16,322 Common Stock | (F2) The stock options vested quarterly over the first year of service and were fully vested on May 10, 2013. |